ConductScience.org, home

Paper35486115

Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.

Musick M and 1 other. Immunol Res, 2022. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors. Papers, record 35486115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35486115

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.
PubMed
Journal
Immunol Res
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.84
iCite
Revised in PubMed
2026-10-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Musick MMaggiehttps://orcid.org/0000-0002-3564-2527
2Yu XXianzhong

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Tumor MicroenvironmentMajor topic
Humans
Immunotherapy
Macrophages
Transcription Factors

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122025054Transcriptional regulation of macrophage polarization: enabling diversity with identity.Nat Rev Immunol2011https://conductscience.org/library/papers/22025054PubMed
232953830Metabolic reprograming of tumor-associated macrophages.Ann Transl Med2020https://conductscience.org/library/papers/32953830PubMed
329313005Biomimetic strategies for targeted nanoparticle delivery.Bioeng Transl Med2016https://conductscience.org/library/papers/29313005PubMed
432724855M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects.ACS Cent Sci2020https://conductscience.org/library/papers/32724855PubMed
531419588Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines.Biomaterials2019https://conductscience.org/library/papers/31419588PubMed
632849616Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.Front Immunol2020https://conductscience.org/library/papers/32849616PubMed
716239969Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.J Clin Invest2005https://conductscience.org/library/papers/16239969PubMed
825339958Macrophage cytokines: involvement in immunity and infectious diseases.Front Immunol2014https://conductscience.org/library/papers/25339958PubMed
920103670Nuclear factor-kappaB and tumor-associated macrophages.Clin Cancer Res2010https://conductscience.org/library/papers/20103670PubMed
1030413827Cytokines in clinical cancer immunotherapy.Br J Cancer2019https://conductscience.org/library/papers/30413827PubMed
1132599709Macrophage Modification Strategies for Efficient Cell Therapy.Cells2020https://conductscience.org/library/papers/32599709PubMed
1225314115Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin.Mol Pharm2014https://conductscience.org/library/papers/25314115PubMed
1318617992RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages.PLoS Pathog2008https://conductscience.org/library/papers/18617992PubMed
1432547552Modulating Cytokine Production via Select Packaging and Secretion From Extracellular Vesicles.Front Immunol2020https://conductscience.org/library/papers/32547552PubMed
1526614117Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.Microcirculation2016https://conductscience.org/library/papers/26614117PubMed
1626335330Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer.PLoS One2015https://conductscience.org/library/papers/26335330PubMed
1729155869NF-κB pathways are involved in M1 polarization of RAW 264.7 macrophage by polyporus polysaccharide in the tumor microenvironment.PLoS One2017https://conductscience.org/library/papers/29155869PubMed
1824379524Interferon-regulatory factors determine macrophage phenotype polarization.Mediators Inflamm2013https://conductscience.org/library/papers/24379524PubMed
1925125485Tumor-associated macrophages as major players in the tumor microenvironment.Cancers (Basel)2014https://conductscience.org/library/papers/25125485PubMed
2023640482Transcriptional control of macrophage polarization.Arterioscler Thromb Vasc Biol2013https://conductscience.org/library/papers/23640482PubMed

See all 91 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42111497Multiomics Characterization of GCSH + Macrophages Reveals Therapeutic Vulnerabilities and Immune-Metabolic Crosstalk in Triple-Negative Breast Cancer.Hum Mutat2026https://conductscience.org/library/papers/42111497PubMed
41147952Dualistic Role of MITF in Uveal Melanoma: Defining Two Distinct Cellular Subpopulations With Prognostic and Therapeutic Implications.Invest Ophthalmol Vis Sci2025https://conductscience.org/library/papers/41147952PubMed
40075571Bacterial-Mediated In Situ Engineering of Tumour-Associated Macrophages for Cancer Immunotherapy.Cancers (Basel)2025https://conductscience.org/library/papers/40075571PubMed
38165530The selection of animal models influences the assessment of anti-tumor efficacy: promising sialic acid-conjugate modified liposomes demonstrate remarkable therapeutic effects in diverse mouse strains.Drug Deliv Transl Res2024https://conductscience.org/library/papers/38165530PubMed
37894541Dendrobium officinale polysaccharide Converts M2 into M1 Subtype Macrophage Polarization via the STAT6/PPAR-r and JAGGED1/NOTCH1 Signaling Pathways to Inhibit Gastric Cancer.Molecules2023https://conductscience.org/library/papers/37894541PubMed
36418765Immunotherapeutic effects of intratumorally injected Zymosan-Adenovirus conjugates encoding constant active IRF3 in a melanoma mouse model.Immunol Res2023https://conductscience.org/library/papers/36418765PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35486115

GET https://conductscience.org/api/papers/v1/35486115/references?page=2